By Colin Kellaher

 

Becton Dickinson & Co. Wednesday said the U.S. Department of Health & Human Services will use its products to expand access to rapid point-of-care testing for Covid-19.

The Franklin Lakes, N.J., medical-technology company said HHS has committed to buy 2,000 BD Veritor Plus Systems, along with 750,000 SARS-CoV-2 antigen test kits, in a bid to expand testing through a broad, decentralized network.

Becton Dickinson said distribution will begin next week.

The U.S. Food and Drug Administration earlier this month granted Becton Dickinson an emergency-use authorization for the BD Veritor Plus System for rapid detection of SARS-CoV-2.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

July 15, 2020 07:32 ET (11:32 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Jul 2020 to Aug 2020 Click Here for more Becton Dickinson Charts.
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Aug 2019 to Aug 2020 Click Here for more Becton Dickinson Charts.